Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
-93.81%
Change (1 year)
Categories
Mallinckrodt Pharmaceuticals (MNK) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $4.48 B
According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's total liabilities are $4.48 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Mallinckrodt Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $4.40 B | -48.85% |
| 2021-12-31 | $8.60 B | -1.07% |
| 2020-12-31 | $8.69 B | 3.55% |
| 2019-12-31 | $8.39 B | 5.11% |
| 2018-12-31 | $7.99 B | -8.78% |
| 2017-12-31 | $8.75 B | |
| 2016-09-30 | $10.22 B | -7.8% |
| 2015-09-30 | $11.09 B | 40.3% |
| 2014-09-30 | $7.90 B | 243.62% |
| 2013-09-30 | $2.30 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 2,104.26% | 🇺🇸 USA |
 General Electric GE | $132.83 B | 2,864.16% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 688.87% | 🇮🇱 Israel |